IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo

Macrophages are an integral part of the innate immune system and key players in pathogen clearance and tissue remodelling. Both functions are accomplished by a pivotal network of different macrophage subtypes, including proinflammatory M1 and anti-inflammatory M2 macrophages. Previously, our laborat...

Full description

Saved in:
Bibliographic Details
Main Authors: Miriam Weiss, Katrina Blazek, Adam J. Byrne, Dany P. Perocheau, Irina A. Udalova
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/245804
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849413710403076096
author Miriam Weiss
Katrina Blazek
Adam J. Byrne
Dany P. Perocheau
Irina A. Udalova
author_facet Miriam Weiss
Katrina Blazek
Adam J. Byrne
Dany P. Perocheau
Irina A. Udalova
author_sort Miriam Weiss
collection DOAJ
description Macrophages are an integral part of the innate immune system and key players in pathogen clearance and tissue remodelling. Both functions are accomplished by a pivotal network of different macrophage subtypes, including proinflammatory M1 and anti-inflammatory M2 macrophages. Previously, our laboratory identified the transcription factor interferon regulatory factor 5 (IRF5) as the master regulator of the M1 macrophage polarisation. IRF5 was found to be highly expressed in human M1 compared to M2 macrophages. Furthermore, IRF5 dictates the expression of proinflammatory genes such as IL12b and IL23a whilst repressing anti-inflammatory genes like IL10. Here we show that murine bone marrow derived macrophages differentiated in vitro with GM-CSF are also characterised by high levels of IRF5 mRNA and protein and express proinflammatory cytokines upon LPS stimulation. These macrophages display characteristic expression of M1-marker MHC II but lack the M2-marker CD206. Significantly, we develop intracellular staining of IRF5- expressing macrophages and utilise it to recapitulate the in vitro results in an in vivo model of antigen-induced arthritis, emphasising their physiological relevance. Thus, we establish the species-invariant role of IRF5 in controlling the inflammatory macrophage phenotype both in vitro and in in vivo.
format Article
id doaj-art-679465d6411d4eb7829a78b3ba8888fb
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-679465d6411d4eb7829a78b3ba8888fb2025-08-20T03:34:02ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/245804245804IRF5 Is a Specific Marker of Inflammatory Macrophages In VivoMiriam Weiss0Katrina Blazek1Adam J. Byrne2Dany P. Perocheau3Irina A. Udalova4Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, UKKennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, UKKennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, UKKennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, UKKennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, UKMacrophages are an integral part of the innate immune system and key players in pathogen clearance and tissue remodelling. Both functions are accomplished by a pivotal network of different macrophage subtypes, including proinflammatory M1 and anti-inflammatory M2 macrophages. Previously, our laboratory identified the transcription factor interferon regulatory factor 5 (IRF5) as the master regulator of the M1 macrophage polarisation. IRF5 was found to be highly expressed in human M1 compared to M2 macrophages. Furthermore, IRF5 dictates the expression of proinflammatory genes such as IL12b and IL23a whilst repressing anti-inflammatory genes like IL10. Here we show that murine bone marrow derived macrophages differentiated in vitro with GM-CSF are also characterised by high levels of IRF5 mRNA and protein and express proinflammatory cytokines upon LPS stimulation. These macrophages display characteristic expression of M1-marker MHC II but lack the M2-marker CD206. Significantly, we develop intracellular staining of IRF5- expressing macrophages and utilise it to recapitulate the in vitro results in an in vivo model of antigen-induced arthritis, emphasising their physiological relevance. Thus, we establish the species-invariant role of IRF5 in controlling the inflammatory macrophage phenotype both in vitro and in in vivo.http://dx.doi.org/10.1155/2013/245804
spellingShingle Miriam Weiss
Katrina Blazek
Adam J. Byrne
Dany P. Perocheau
Irina A. Udalova
IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
Mediators of Inflammation
title IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
title_full IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
title_fullStr IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
title_full_unstemmed IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
title_short IRF5 Is a Specific Marker of Inflammatory Macrophages In Vivo
title_sort irf5 is a specific marker of inflammatory macrophages in vivo
url http://dx.doi.org/10.1155/2013/245804
work_keys_str_mv AT miriamweiss irf5isaspecificmarkerofinflammatorymacrophagesinvivo
AT katrinablazek irf5isaspecificmarkerofinflammatorymacrophagesinvivo
AT adamjbyrne irf5isaspecificmarkerofinflammatorymacrophagesinvivo
AT danypperocheau irf5isaspecificmarkerofinflammatorymacrophagesinvivo
AT irinaaudalova irf5isaspecificmarkerofinflammatorymacrophagesinvivo